HIVEP2-DT and ocular melanoma: In a parallel approach to the recombinant PE-PilA, Novotny et al. found that ChimV4, a fusion of P5 peptide and rsPilA resolved NTHi-induced OM when delivered transcutaneously (Novotny et al., 2015a).